EMFAT
COGT icon

Emerald Mutual Fund Advisers Trust’s Cogent Biosciences COGT Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.9M Buy
1,031,378
+2,546
+0.2% +$89.1K 1.4% 19
2026
Q1 		$39.6M Sell
1,028,832
-9,662
-0.9% -$357K 1.92% 6
2025
Q4 		$36.9M Buy
1,038,494
+15,636
+2% +$440K 1.8% 6
2025
Q3 		$14.7M Buy
1,022,858
+127,446
+14% +$1.51M 0.76% 51
2025
Q2 		$6.43M Buy
+895,412
New +$4.96M 0.39% 92

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's COGT Position: Q2 2026 in Review

Emerald Mutual Fund Advisers Trust increased its Cogent Biosciences (COGT) stake by 0.25% in Q2 2026, buying an estimated $89.1K and bringing the position to 1,031,378 shares worth $39.9M. The position accounts for 1.4% of the portfolio, ranked #19.

Emerald Mutual Fund Advisers Trust first reported a position in COGT in Q2 2025 and has held it in 5 quarters since. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Emerald Mutual Fund Advisers Trust held 1,031,378 shares of Cogent Biosciences worth $39.9M as of Q2 2026.
  • Emerald Mutual Fund Advisers Trust bought 2,546 Cogent Biosciences shares in Q2 2026, an estimated $89.1K.
  • Cogent Biosciences made up 1.4% of Emerald Mutual Fund Advisers Trust's portfolio in Q2 2026, its #19 holding.
  • Emerald Mutual Fund Advisers Trust first reported a position in Cogent Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2026, filed 5 Aug 2026.